DUBLIN--(BUSINESS WIRE)--Aug 30, 2018--The "Biotechnology - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.

Factors such as growing demand for agro-based products, reducing cost of DNA sequencing, rising prevalence of chronic disorder are driving the market growth. However, ethical issues associated with clinical trials and risks associated with GM organisms and crops are restraining the market growth.

By technology, the nanobiotechnology is expected to dominate the market. Various drug delivery therapies use nanobiotechnology for chronic disorders such as cancer. It involves the advancement of nanoparticle based gold nanoparticles, chemotherapeutic drugs, and quantum dots for molecular diagnosis and nanobiosensors which help in drug delivery and optical imaging.

North America accounted for largest market share attributed to the increase in investments in R&D pertaining to new drug discovery.

Key Topics Covered

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porter's Five Forces Analysis

5 Global Biotechnology Market, By Technology

6 Global Biotechnology Market, By Application

7 Global Biotechnology Market, By Geography

8 Key Developments

9 Company Profiling

Gilead Biogen Celgene Corporation AstraZeneca Abbott Laboratories Novo Nordisk A/S Novartis AG Lonza Amgen Inc. F. Hoffmann-La Roche Ltd. Johnson & Johnson Services Inc. Pfizer Inc. Sanofi Aventis Merck & Co Roche Genentech

For more information about this report visit https://www.researchandmarkets.com/research/jbt2fw/biotechnology?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180830005539/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biotechnology

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/30/2018 10:35 AM/DISC: 08/30/2018 10:35 AM

http://www.businesswire.com/news/home/20180830005539/en